Eurosets Launches U.S. Commercialization of Trilly and Horizon Following FDA Clearance and Enters Strategic Partnership with Orion Medical
Eurosets is pleased to announce the official start of U.S. commercialization for the Trilly and Horizon oxygenators, following successful FDA 510(k) clearance. This milestone reflects our commitment to supporting clinicians with reliable, high-performance technologies at a time when the U.S. healthcare system continues to face a critical and growing need for oxygenators and life-support solutions.
